Elotuzumab Market Statistics and Industry Forecast at 7.6% CAGR (2026–2034)
According to a new report from Intel Market Research, the global Elotuzumab market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.85 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is driven by increasing prevalence of multiple myeloma, advancements in immunotherapy, and...